Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/07/1995 | WO1995033052A1 Immunosuppressant target proteins |
12/07/1995 | WO1995033051A1 Tumor necrosis factor receptor-associated factors |
12/07/1995 | WO1995033050A1 Flt-4 (fms-like tyrosine-kinase), flt-15, variants thereof uses as growth factor inhibitors |
12/07/1995 | WO1995033049A2 Tbp2 FRAGMENTS OF THE TRANSFERRINE RECEPTOR OF NEISSERIA MENINGITIDIS |
12/07/1995 | WO1995033048A2 P2x receptors (purinoceptor family) |
12/07/1995 | WO1995032992A1 Synthetic peptide analogs of lung surfactant protein sp-c |
12/07/1995 | WO1995032991A1 Growth hormone therapy and related methods and pharmaceutical compositions |
12/07/1995 | WO1995032988A1 Novel parasite protease genes and proteins |
12/07/1995 | WO1995032738A1 Modification of clostridial toxins for use as transport proteins |
12/07/1995 | WO1995032734A1 New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness |
12/07/1995 | WO1995032733A1 Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen |
12/07/1995 | WO1995032731A2 Immunogenic pharmaceuticals |
12/07/1995 | WO1995032729A1 Short-term anti-cd3 stimulation of lymphocytes to increase their in vivo activity |
12/07/1995 | WO1995032728A1 Inhibition of attachment of h. influenzae to human cells |
12/07/1995 | WO1995032727A1 Inhibition of infection of mammalian cells by respiratory syncytial virus |
12/07/1995 | WO1995032724A1 Glial mitogenic factors, their preparation and use |
12/07/1995 | WO1995032709A1 Activation of growth factors by matrix vesicles |
12/07/1995 | WO1995032706A1 Virosome-mediated intracellular delivery of therapeutic agents |
12/07/1995 | WO1995032627A1 Use of fas ligand to suppress lymphocyte-mediated immune responses |
12/07/1995 | WO1995030435A3 Compositions and treatment for multiple sclerosis |
12/07/1995 | WO1995028907A3 Megapoietin: a novel megakaryocyte growth promoting factor |
12/07/1995 | WO1995026980A3 Haptenated peptides and uses thereof |
12/07/1995 | WO1995025749A3 Eating suppressant peptides |
12/07/1995 | WO1995024485A3 Coordinate in vivo gene expression |
12/07/1995 | WO1995021919A3 Protein having tpo activity |
12/07/1995 | WO1995020669A3 Soybean cyst nematode resistant soybeans and methods of breeding and identifying resistant plants |
12/07/1995 | DE4435919C1 DNA encoding zinc finger protein |
12/07/1995 | DE4419294A1 Legionella pneumophila DNA coding for major outer membrane protein |
12/07/1995 | DE4418825A1 Transfection of eukaryotic cells |
12/07/1995 | DE19513784A1 Hochreines Urodilatin und Verfahren zu seiner Herstellung High purity urodilatin and process for its preparation |
12/07/1995 | CA2191430A1 Detection of different hiv genotypes utilizing a synthetic peptide-modified immunoassay |
12/07/1995 | CA2191321A1 Gene coding for modified bone morphogenic protein receptor |
12/07/1995 | CA2191306A1 Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation |
12/07/1995 | CA2191085A1 Glial mitogenic factors, their preparation and use |
12/07/1995 | CA2191071A1 Flt-4 (fms-like tyrosine kinase), flt-15, variants thereof used as growth factor inhibitors |
12/07/1995 | CA2190963A1 Method for introducing foreign matter into higher eukaryotic cells |
12/07/1995 | CA2190610A1 Inhibition of attachment of h. influenzae to human cells |
12/07/1995 | CA2190609A1 Inhibition of infection of mammalian cells by respiratory syncytial virus |
12/07/1995 | CA2190265A1 Hepatitis c virus asialoglycoproteins |
12/07/1995 | CA2190254A1 Tumor necrosis factor receptor-associated factors |
12/07/1995 | CA2189741A1 Novel parasite protease genes and proteins |
12/07/1995 | CA2188812A1 New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness |
12/07/1995 | CA2188449A1 Electromagnetically controlled gear engagement mechanism integrated with a magnetic hysteresis slip clutch |
12/07/1995 | CA2187731A1 Activation of growth factors by matrix vesicles |
12/07/1995 | CA2167936A1 Tbp2 fragments of the transferrine receptor of neisseria meningitidis |
12/06/1995 | EP0685560A2 Method for controlling gene expression |
12/06/1995 | EP0685558A1 Transgenic animals lacking proteolipid protein and method of making such animals |
12/06/1995 | EP0685493A1 Tumor suppressor fusion proteins |
12/06/1995 | EP0685492A2 Process for the preparation of hyperpolymers of haemoglobin with uniform molecular weight |
12/06/1995 | EP0685491A2 Process for producing albumin preparation |
12/06/1995 | EP0685490A1 Process for the purification of homogeneous platelet-derived endothelial cell growth factor from a platelet lysate |
12/06/1995 | EP0685236A1 Prevention and treatment of retroviral disease |
12/06/1995 | EP0684999A1 Sequence-directed dna-binding molecules compositions and methods |
12/06/1995 | EP0684997A1 Anthrax toxin fusion proteins and uses thereof |
12/06/1995 | EP0684996A1 Cs31a protein capsule subunit modified by at least one heterologous peptide, cs31a protein capsule comprising said subunit, micro-organisms having such subunits on their outer membrane, and methods for preparing and using same |
12/06/1995 | EP0684995A1 Brazzein sweetener |
12/06/1995 | EP0684993A1 Human dna sequence encoding a kidney atp-dependent potassium channel |
12/06/1995 | EP0684992A1 Method for obtaining an increased production of a producing celline by using a fusion protocol |
12/06/1995 | EP0684990A1 Novel receptor-type phosphotyrosine phosphatase-gamma |
12/06/1995 | EP0684989A1 Novel receptor-type phosphotyrosine phosphatase-beta |
12/06/1995 | EP0684957A1 $i(STREPTOCOCCUS SUIS) ADHESIN PROTEIN AND METHOD FOR PRODUCING IT |
12/06/1995 | EP0684956A1 Acylated protein aggregates and their use in enhancing signals in an immunoassay testing for antibodies |
12/06/1995 | EP0684955A1 Nuclear matrix proteins |
12/06/1995 | EP0684843A1 TECHNETIUM-99m LABELED PEPTIDES FOR DIAGNOSTIC IMAGING |
12/06/1995 | EP0684841A1 Protein conjugates, compositions containing them and their applications as medicament |
12/06/1995 | EP0684837A1 Methods for modifying the t cell repertoire of the immune system |
12/06/1995 | EP0684835A1 Ligand antagonists for treatment of breast cancer |
12/06/1995 | EP0684831A1 Allogeneic vaccine and method to synthesize same |
12/06/1995 | EP0684829A1 Role of atp-ubiquitin-dependent proteolysis in mhc-1 restricted antigen presentation and inhibitors thereof |
12/06/1995 | EP0684759A1 Transgenic pomaceous fruit with fire blight resistance |
12/06/1995 | EP0593580A4 Sequences characteristic of human gene transcription product |
12/06/1995 | EP0529076B1 Proteins with fibroblast growth factor receptor activity |
12/06/1995 | EP0490998B1 Transferrin receptor specific antibody-neuropharmaceutical agent conjugates |
12/06/1995 | EP0484340B1 Treatment to reduce edema for brain and musculature injuries |
12/06/1995 | EP0429542B1 Leukocyte adhesion inhibitor |
12/06/1995 | EP0409962B1 Agent for inhibiting hiv-proteases |
12/06/1995 | CN1112933A Antigen-specific, activated T lymphocytes, detection and use |
12/06/1995 | CN1112931A Schistosome vaccine peptide No.3 |
12/06/1995 | CN1112930A Schistosome vaccine peptide No.2 |
12/05/1995 | USH1509 Heparin enhanced process for separating antihemophilic factor (Factor VIII) and fibronectin from cryoprecipitate |
12/05/1995 | US5473056 For study of cell cycle regulation and of Rb tumor suppressor protein and of viral oncogenes |
12/05/1995 | US5473054 IGF-1 analogs |
12/05/1995 | US5473052 Antigen-binding fragments of an antibody to type-I collagen amino-terminal telopeptide |
12/05/1995 | US5473051 Inhibition of Mac-1 receptor binding to fibrinogen using D30 homologs |
12/05/1995 | US5473049 Process for obtaining proinsulin possessing correctly linked cystine bridges |
12/05/1995 | US5473039 Inhibit lymphocyte proliferation |
12/05/1995 | US5473034 Method for producing protein-synthetic polymer conjugate and said conjugate produced thereby |
12/05/1995 | US5472985 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
12/05/1995 | US5472945 Modulation of blood pressure and inhibition of platelet activation with kininogen fragment |
12/05/1995 | US5472944 Suppression of megakaryocytopoiesis by neutrophil activating peptide-2 |
12/05/1995 | US5472942 Anti-thrombins |
12/05/1995 | US5472939 Method of treating complement mediated disorders |
12/05/1995 | US5472884 To determine rate of bone resorption; quantitating crosslinked collagen telopeptides in control and test samples and in vivo; kits; detecting osteoporosis |
12/05/1995 | US5472871 Isolation and characterization of the nematode HER-1 Gene and protein product |
12/05/1995 | US5472866 DNA encoding 5-HT4A serotonin receptors |
12/05/1995 | US5472858 Production of recombinant proteins in insect larvae |
12/05/1995 | US5472857 DNA encoding canine granulocyte colony stimulating factor (G-CSF) |
12/05/1995 | US5472856 Recombinant human thymopoietin proteins and uses therefor |
12/05/1995 | US5472844 Hybridizing oligonucleotide; incubation forming a duplex |
12/05/1995 | US5472841 Methods for identifying nucleic acid ligands of human neutrophil elastase |